SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016871
Filing Date
2023-10-26
Accepted
2023-10-26 16:50:17
Documents
13
Period of Report
2023-10-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20231024x8k.htm   iXBRL 8-K 40387
  Complete submission text file 0001558370-23-016871.txt   199435

Data Files

Seq Description Document Type Size
2 EX-101.SCH fbio-20231024.xsd EX-101.SCH 4464
3 EX-101.DEF fbio-20231024_def.xml EX-101.DEF 14893
4 EX-101.LAB fbio-20231024_lab.xml EX-101.LAB 17168
5 EX-101.PRE fbio-20231024_pre.xml EX-101.PRE 14858
7 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20231024x8k_htm.xml XML 7276
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 231350827
SIC: 2834 Pharmaceutical Preparations